ANDA Process: Legal Requirements for Generic Drug Approval
Explore the legal and regulatory requirements of the ANDA process for generic drug approval. Learn about Hatch-Waxman, bioequivalence, patent certifications, and FDA fees.
Tag: Hatch-Waxman Act
How the FDA Ensures Generic Drugs Work the Same as Brand-Name Medications
Discover how the FDA guarantees generic drugs match brand-name efficacy through bioequivalence testing, the ANDA process, and strict manufacturing standards under the Hatch-Waxman Act.
Hatch-Waxman Act Explained: How It Balances Brand Patents and Generic Drug Approval
The Hatch-Waxman Act balances brand patent protection with generic drug competition. Learn how the ANDA process, Orange Book listings, and 180-day exclusivity rules drive down medication costs for millions of Americans.
Generic Patent Case Law: Landmark Court Decisions That Shape Drug Prices
Landmark court decisions in generic patent law shape drug prices and access. Key rulings like Amgen v. Sanofi and Allergan v. Teva define how generics challenge patents, use the Orange Book, and navigate the Hatch-Waxman Act-impacting millions of patients.